These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12819464)

  • 1. Tumor necrosis factor biology in experimental and clinical arthritis.
    Sfikakis PP; Kollias G
    Curr Opin Rheumatol; 2003 Jul; 15(4):380-6. PubMed ID: 12819464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysing the effect of novel therapies on cytokine expression in experimental arthritis.
    Williams RO; Inglis JJ; Simelyte E; Criado G; Sumariwalla PF
    Int J Exp Pathol; 2005 Oct; 86(5):267-78. PubMed ID: 16191099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis.
    Delavallée L; Semerano L; Assier E; Vogel G; Vuagniaux G; Laborie M; Zagury D; Bessis N; Boissier MC
    Arthritis Res Ther; 2009; 11(6):R195. PubMed ID: 20030816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Broad Blockade of Signaling from the IL-20 Family of Cytokines Potently Attenuates Collagen-Induced Arthritis.
    Liu X; Zhou H; Huang X; Cui J; Long T; Xu Y; Liu H; Yu R; Zhao R; Luo G; Huang A; Liang JG; Liang P
    J Immunol; 2016 Oct; 197(8):3029-3037. PubMed ID: 27619991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
    Mugnier B; Bouvenot G
    Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
    Feldmann M
    Int Arch Allergy Immunol; 1996 Dec; 111(4):362-5. PubMed ID: 8957109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis.
    Maini RN; Elliott M; Brennan FM; Williams RO; Feldmann M
    APMIS; 1997 Apr; 105(4):257-63. PubMed ID: 9164467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TNF-alpha transgenic mouse model of inflammatory arthritis.
    Li P; Schwarz EM
    Springer Semin Immunopathol; 2003 Aug; 25(1):19-33. PubMed ID: 12904889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice.
    Utku N; Heinemann T; Winter M; Bulwin CG; Schlawinsky M; Fraser P; Nieuwenhuis EE; Volk HD; Blumberg RS
    Clin Exp Immunol; 2006 Apr; 144(1):142-51. PubMed ID: 16542376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.
    McCann FE; Perocheau DP; Ruspi G; Blazek K; Davies ML; Feldmann M; Dean JL; Stoop AA; Williams RO
    Arthritis Rheumatol; 2014 Oct; 66(10):2728-38. PubMed ID: 24965881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α inhibitor reverse the effects of human umbilical cord-derived stem cells on experimental arthritis by increasing immunosuppression.
    Wu CC; Wu TC; Liu FL; Sytwu HK; Chang DM
    Cell Immunol; 2012; 273(1):30-40. PubMed ID: 22196378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric anti-IL-17 full-length monoclonal antibody is a novel potential candidate for the treatment of rheumatoid arthritis.
    Bai F; Tian H; Niu Z; Liu M; Ren G; Yu Y; Sun T; Li S; Li D
    Int J Mol Med; 2014 Mar; 33(3):711-21. PubMed ID: 24378614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
    Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
    Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.
    Feldmann M; Elliott MJ; Woody JN; Maini RN
    Adv Immunol; 1997; 64():283-350. PubMed ID: 9100984
    [No Abstract]   [Full Text] [Related]  

  • 17. TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.
    Mukherjee P; Wu B; Mayton L; Kim SH; Robbins PD; Wooley PH
    Ann Rheum Dis; 2003 Aug; 62(8):707-14. PubMed ID: 12860724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.
    Roord ST; Zonneveld-Huijssoon E; Le T; Yung GP; Koffeman E; Ronaghy A; Ghahramani N; Lanza P; Billetta R; Prakken BJ; Albani S
    PLoS One; 2006 Dec; 1(1):e87. PubMed ID: 17183718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.
    Kollias G; Douni E; Kassiotis G; Kontoyiannis D
    Immunol Rev; 1999 Jun; 169():175-94. PubMed ID: 10450517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targets in immune-mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis.
    Campbell IK; Roberts LJ; Wicks IP
    Immunol Cell Biol; 2003 Oct; 81(5):354-66. PubMed ID: 12969323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.